Morgan Stanley raised the firm’s price target on CME Group (CME) to $263 from $256 and keeps an Equal Weight rating on the shares. In a model refresh following Q4 results, the firm is raising its 2025 adjusted EPS view by 3.6% to $10.97 from $10.59.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME: